Literature DB >> 2903055

Guillain-Barré syndrome and serum activities of gamma-glutamyltransferase and glutamic-pyruvic transaminase.

J Kornhuber1, A W Kornhuber, C H Kaiserauer, W E Wanner.   

Abstract

Objective laboratory indicators of alcohol consumption (mean corpuscular volume and serum glutamic-pyruvic transaminase (GPT), glutamyltransferase (gamma-GT), and glutamic-oxaloacetic transaminase (GOT] were measured in 18 patients with Guillain-Barré syndrome (GBS) and 710 control patients. All of the indicators examined were more frequently found to be pathological in GBS patients, reaching significance for gamma-GT and GPT. Some explanations for this result are discussed. It is concluded that alcohol consumption may be a risk factor for GBS.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903055     DOI： 10.1007/bf00380973

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN： 0175-758X


  12 in total

1.  Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine.

Authors:  E Beghi; L T Kurland; D W Mulder; W C Wiederholt
Journal:  Arch Neurol       Date:  1985-11

2.  Transfer of demyelination by intraneural injection of experimental allergic neuritis serum.

Authors:  T Saida; K Saida; D H Silberberg; M J Brown
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

3.  Passive transfer of demyelination by experimental allergic neuritis serum.

Authors:  A F Hahn; J J Gilbert; T E Feasby
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

4.  Immune responses in experimental allergic neuritis.

Authors:  R A Hughes; M Kadlubowski; I A Gray; S Leibowitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-07       Impact factor: 10.154

5.  Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man.

Authors:  J Kornhuber; C H Kaiserauer; A W Kornhuber; M E Kornhuber
Journal:  Neurosci Lett       Date:  1987-08-18       Impact factor: 3.046

6.  Early changes in experimental allergic neuritis.

Authors:  H C Powell; S L Braheny; R R Myers; M Rodriguez; P W Lampert
Journal:  Lab Invest       Date:  1983-03       Impact factor: 5.662

7.  In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.

Authors:  T Saida; K Saida; R P Lisak; M J Brown; D H Silberberg; A K Asbury
Journal:  Ann Neurol       Date:  1982-01       Impact factor: 10.422

8.  Urinary tract infections and renal papillary necrosis in alcoholism.

Authors:  T O Pitts; D H Van Thiel
Journal:  Recent Dev Alcohol       Date:  1986

9.  Guillain-Barré syndrome: its epidemiology and associations with influenza vaccination.

Authors:  L B Schonberger; E S Hurwitz; P Katona; R C Holman; D J Bregman
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

10.  Diagnostic considerations in Guillain-Barré syndrome.

Authors:  A K Asbury
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.